... Spray, Nycomed US, Labeling Revision Relenza (zanamivir) Inhalation Powder, GlaxoSmithKline, Labeling Revision Tramadol Hydrochloride Extended-Release Capsules, Wilcox and Savage, Approval Trandolapril and Verapamil Hydrochloride Extended-Release Tablets, Glenmark Generics Inc, Approval Tylenol (acetaminophen) Extended-Release Tablets, McNeil Consumer Healthcare, Manufacturing Change or Addition May 11, 2010 Acephen (acetaminophen) Suppository, G and W Laboratories, Inc, Labeling Revision Blenoxane (Bleomycin sulfate) Injection, Bristol-Myers Squibb, Labeling Revision Catapres-TTS (clonidine) Patch, Boehringer Ingelheim, Labeling Revision Colcrys (colchicine) Tablets, AR Holding Company, Inc, Labeling Revision Creon (pancrelipase) Delayed-Release Capsules, Abbott Products, Inc, Patient Population Altered Femara (letrozole) Tablets, Novartis Pharmaceuticals Corp. Efficacy Supplement with Clinical Data to Support Hyphanox (itraconazole) Tablets, Stiefel Laboratories, Inc, Approval Irinotecan Hydrochloride Injection, Dr. Reddy's Laboratories, Ltd, Approval Midol Liquid Gels (ibuprofen) Capsules, Banner Pharmacaps Inc, Labeling Revision Norvir (ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision Remicade (infliximab) Intravenous Injection, ...